Sanofi Belgium
SpainAll drugs from this manufacturer
-
It is used to treat a form of multiple sclerosis (MS) in adults called relapsing-remitting multiple sclerosis (RRMS). It helps reduce the number of relapses and may slow down or reverse some signs and symptoms of the disease.
Dosage form: solution for infusion, concentrate
Active substance Dosage alemtuzumab 10,0 mg